The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cholesterol Rapid Tests Market Research Report 2024
Synopsis
Cholesterol is a substance (a steroid) that is essential for life. It forms the membranes for cells in all organs and tissues in the body. It is used to make hormones that are essential for development, growth, and reproduction. It forms bile acids that are needed to absorb nutrients from food. The test for cholesterol measures total cholesterol that is carried in the blood by lipoproteins. This report mainly covers the cholesterol rapid tests, which is used for cardiovascular diseases applications.
The global Cholesterol Rapid Tests market was valued at US$ 442 million in 2023 and is anticipated to reach US$ 609.5 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for Cholesterol Rapid Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cholesterol Rapid Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cholesterol Rapid Tests include Abbott, PRIMA Lab SA, Jant Pharmacal, CIGA Healthcare Ltd, PTS Diagnostics, Chematics, Acon Labs, Easylife and Roche Diangnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cholesterol Rapid Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholesterol Rapid Tests.
Report Scope
The Cholesterol Rapid Tests market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholesterol Rapid Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholesterol Rapid Tests manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
PRIMA Lab SA
Jant Pharmacal
CIGA Healthcare Ltd
PTS Diagnostics
Chematics
Acon Labs
Easylife
Roche Diangnostics
Abaxis, Inc
Akers
Suresign
Segment by Type
Point-of-care Testing
Lateral Flow Rapid Test
Segment by Application
Hospital
Clinic
Family
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cholesterol Rapid Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cholesterol Rapid Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cholesterol is a substance (a steroid) that is essential for life. It forms the membranes for cells in all organs and tissues in the body. It is used to make hormones that are essential for development, growth, and reproduction. It forms bile acids that are needed to absorb nutrients from food. The test for cholesterol measures total cholesterol that is carried in the blood by lipoproteins. This report mainly covers the cholesterol rapid tests, which is used for cardiovascular diseases applications.
The global Cholesterol Rapid Tests market was valued at US$ 442 million in 2023 and is anticipated to reach US$ 609.5 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for Cholesterol Rapid Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cholesterol Rapid Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cholesterol Rapid Tests include Abbott, PRIMA Lab SA, Jant Pharmacal, CIGA Healthcare Ltd, PTS Diagnostics, Chematics, Acon Labs, Easylife and Roche Diangnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cholesterol Rapid Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholesterol Rapid Tests.
Report Scope
The Cholesterol Rapid Tests market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholesterol Rapid Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholesterol Rapid Tests manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
PRIMA Lab SA
Jant Pharmacal
CIGA Healthcare Ltd
PTS Diagnostics
Chematics
Acon Labs
Easylife
Roche Diangnostics
Abaxis, Inc
Akers
Suresign
Segment by Type
Point-of-care Testing
Lateral Flow Rapid Test
Segment by Application
Hospital
Clinic
Family
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cholesterol Rapid Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cholesterol Rapid Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cholesterol Rapid Tests Market Overview
1.1 Product Overview and Scope of Cholesterol Rapid Tests
1.2 Cholesterol Rapid Tests Segment by Type
1.2.1 Global Cholesterol Rapid Tests Market Value Comparison by Type (2024-2030)
1.2.2 Point-of-care Testing
1.2.3 Lateral Flow Rapid Test
1.3 Cholesterol Rapid Tests Segment by Application
1.3.1 Global Cholesterol Rapid Tests Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Family
1.3.5 Other
1.4 Global Cholesterol Rapid Tests Market Size Estimates and Forecasts
1.4.1 Global Cholesterol Rapid Tests Revenue 2019-2030
1.4.2 Global Cholesterol Rapid Tests Sales 2019-2030
1.4.3 Global Cholesterol Rapid Tests Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cholesterol Rapid Tests Market Competition by Manufacturers
2.1 Global Cholesterol Rapid Tests Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cholesterol Rapid Tests Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cholesterol Rapid Tests Average Price by Manufacturers (2019-2024)
2.4 Global Cholesterol Rapid Tests Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cholesterol Rapid Tests, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cholesterol Rapid Tests, Product Type & Application
2.7 Cholesterol Rapid Tests Market Competitive Situation and Trends
2.7.1 Cholesterol Rapid Tests Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cholesterol Rapid Tests Players Market Share by Revenue
2.7.3 Global Cholesterol Rapid Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cholesterol Rapid Tests Retrospective Market Scenario by Region
3.1 Global Cholesterol Rapid Tests Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cholesterol Rapid Tests Global Cholesterol Rapid Tests Sales by Region: 2019-2030
3.2.1 Global Cholesterol Rapid Tests Sales by Region: 2019-2024
3.2.2 Global Cholesterol Rapid Tests Sales by Region: 2025-2030
3.3 Global Cholesterol Rapid Tests Global Cholesterol Rapid Tests Revenue by Region: 2019-2030
3.3.1 Global Cholesterol Rapid Tests Revenue by Region: 2019-2024
3.3.2 Global Cholesterol Rapid Tests Revenue by Region: 2025-2030
3.4 North America Cholesterol Rapid Tests Market Facts & Figures by Country
3.4.1 North America Cholesterol Rapid Tests Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cholesterol Rapid Tests Sales by Country (2019-2030)
3.4.3 North America Cholesterol Rapid Tests Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cholesterol Rapid Tests Market Facts & Figures by Country
3.5.1 Europe Cholesterol Rapid Tests Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cholesterol Rapid Tests Sales by Country (2019-2030)
3.5.3 Europe Cholesterol Rapid Tests Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cholesterol Rapid Tests Market Facts & Figures by Country
3.6.1 Asia Pacific Cholesterol Rapid Tests Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cholesterol Rapid Tests Sales by Country (2019-2030)
3.6.3 Asia Pacific Cholesterol Rapid Tests Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cholesterol Rapid Tests Market Facts & Figures by Country
3.7.1 Latin America Cholesterol Rapid Tests Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cholesterol Rapid Tests Sales by Country (2019-2030)
3.7.3 Latin America Cholesterol Rapid Tests Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cholesterol Rapid Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa Cholesterol Rapid Tests Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cholesterol Rapid Tests Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cholesterol Rapid Tests Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cholesterol Rapid Tests Sales by Type (2019-2030)
4.1.1 Global Cholesterol Rapid Tests Sales by Type (2019-2024)
4.1.2 Global Cholesterol Rapid Tests Sales by Type (2025-2030)
4.1.3 Global Cholesterol Rapid Tests Sales Market Share by Type (2019-2030)
4.2 Global Cholesterol Rapid Tests Revenue by Type (2019-2030)
4.2.1 Global Cholesterol Rapid Tests Revenue by Type (2019-2024)
4.2.2 Global Cholesterol Rapid Tests Revenue by Type (2025-2030)
4.2.3 Global Cholesterol Rapid Tests Revenue Market Share by Type (2019-2030)
4.3 Global Cholesterol Rapid Tests Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cholesterol Rapid Tests Sales by Application (2019-2030)
5.1.1 Global Cholesterol Rapid Tests Sales by Application (2019-2024)
5.1.2 Global Cholesterol Rapid Tests Sales by Application (2025-2030)
5.1.3 Global Cholesterol Rapid Tests Sales Market Share by Application (2019-2030)
5.2 Global Cholesterol Rapid Tests Revenue by Application (2019-2030)
5.2.1 Global Cholesterol Rapid Tests Revenue by Application (2019-2024)
5.2.2 Global Cholesterol Rapid Tests Revenue by Application (2025-2030)
5.2.3 Global Cholesterol Rapid Tests Revenue Market Share by Application (2019-2030)
5.3 Global Cholesterol Rapid Tests Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Cholesterol Rapid Tests Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 PRIMA Lab SA
6.2.1 PRIMA Lab SA Corporation Information
6.2.2 PRIMA Lab SA Description and Business Overview
6.2.3 PRIMA Lab SA Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PRIMA Lab SA Cholesterol Rapid Tests Product Portfolio
6.2.5 PRIMA Lab SA Recent Developments/Updates
6.3 Jant Pharmacal
6.3.1 Jant Pharmacal Corporation Information
6.3.2 Jant Pharmacal Description and Business Overview
6.3.3 Jant Pharmacal Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jant Pharmacal Cholesterol Rapid Tests Product Portfolio
6.3.5 Jant Pharmacal Recent Developments/Updates
6.4 CIGA Healthcare Ltd
6.4.1 CIGA Healthcare Ltd Corporation Information
6.4.2 CIGA Healthcare Ltd Description and Business Overview
6.4.3 CIGA Healthcare Ltd Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CIGA Healthcare Ltd Cholesterol Rapid Tests Product Portfolio
6.4.5 CIGA Healthcare Ltd Recent Developments/Updates
6.5 PTS Diagnostics
6.5.1 PTS Diagnostics Corporation Information
6.5.2 PTS Diagnostics Description and Business Overview
6.5.3 PTS Diagnostics Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PTS Diagnostics Cholesterol Rapid Tests Product Portfolio
6.5.5 PTS Diagnostics Recent Developments/Updates
6.6 Chematics
6.6.1 Chematics Corporation Information
6.6.2 Chematics Description and Business Overview
6.6.3 Chematics Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chematics Cholesterol Rapid Tests Product Portfolio
6.6.5 Chematics Recent Developments/Updates
6.7 Acon Labs
6.6.1 Acon Labs Corporation Information
6.6.2 Acon Labs Description and Business Overview
6.6.3 Acon Labs Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Acon Labs Cholesterol Rapid Tests Product Portfolio
6.7.5 Acon Labs Recent Developments/Updates
6.8 Easylife
6.8.1 Easylife Corporation Information
6.8.2 Easylife Description and Business Overview
6.8.3 Easylife Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Easylife Cholesterol Rapid Tests Product Portfolio
6.8.5 Easylife Recent Developments/Updates
6.9 Roche Diangnostics
6.9.1 Roche Diangnostics Corporation Information
6.9.2 Roche Diangnostics Description and Business Overview
6.9.3 Roche Diangnostics Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Diangnostics Cholesterol Rapid Tests Product Portfolio
6.9.5 Roche Diangnostics Recent Developments/Updates
6.10 Abaxis, Inc
6.10.1 Abaxis, Inc Corporation Information
6.10.2 Abaxis, Inc Description and Business Overview
6.10.3 Abaxis, Inc Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abaxis, Inc Cholesterol Rapid Tests Product Portfolio
6.10.5 Abaxis, Inc Recent Developments/Updates
6.11 Akers
6.11.1 Akers Corporation Information
6.11.2 Akers Cholesterol Rapid Tests Description and Business Overview
6.11.3 Akers Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Akers Cholesterol Rapid Tests Product Portfolio
6.11.5 Akers Recent Developments/Updates
6.12 Suresign
6.12.1 Suresign Corporation Information
6.12.2 Suresign Cholesterol Rapid Tests Description and Business Overview
6.12.3 Suresign Cholesterol Rapid Tests Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Suresign Cholesterol Rapid Tests Product Portfolio
6.12.5 Suresign Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cholesterol Rapid Tests Industry Chain Analysis
7.2 Cholesterol Rapid Tests Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cholesterol Rapid Tests Production Mode & Process
7.4 Cholesterol Rapid Tests Sales and Marketing
7.4.1 Cholesterol Rapid Tests Sales Channels
7.4.2 Cholesterol Rapid Tests Distributors
7.5 Cholesterol Rapid Tests Customers
8 Cholesterol Rapid Tests Market Dynamics
8.1 Cholesterol Rapid Tests Industry Trends
8.2 Cholesterol Rapid Tests Market Drivers
8.3 Cholesterol Rapid Tests Market Challenges
8.4 Cholesterol Rapid Tests Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
